Page 304 - Read Online

Zimmermann et al. Vessel Plus 2019;3:31 I http://dx.doi.org/10.20517/2574-1209.2019.010 Page 17 of 18

a prospective, multicenter, post-approval study. Circ Cardiovasc Interv 2017;10:e004212.
90. Spies C, Timmermanns I, Schräder R. Transcatheter closure of secundum atrial septal defects in adults with the Amplatzer septal
occluder: intermediate and long-term results. Clin Res Cardiol 2007;96:340.
91. Tomar M, Khatri S, Radhakrishnan S, Shrivastava S. Intermediate and long-term followup of percutaneous device closure of fossa
ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients. Ann Pediatr Cardiol 2011;4:22-7.
92. Villablanca PA, Briston DA, Rodés-Cabau J, Briceno DF, Rao G, et al. Treatment options for the closure of secundum atrial septal
defects: a systematic review and meta-analysis. Int J Cardiol 2017;241:149-55.
93. Akagi T. Catheter intervention for adult patients with congenital heart disease. J Cardiol 2012;60:151-9.
94. Maeno YV. Dynamic morphology of the secundum atrial septal defect evaluated by three dimensional transoesophageal
echocardiography. Heart 2000;83:673-7.
95. Acar P, Saliba Z, Bonhoeffer P, Aggoun Y, Bonnet D, et al. Influence of atrial septal defect anatomy in patient selection and assessment
of closure with the Cardioseal device; a three-dimensional transoesophageal echocardiographic reconstruction. Eur Heart J 2000;21:573-
81.
96. Yang MC, Wu JR. Recent review of transcatheter closure of atrial septal defect. Kaohsiung J Med Sci 2018;34:363-9.
97. Boon I, Vertongen K, Paelinck BP, Demulier L, Van Berendoncks A, et al. How to Size ASDs for Percutaneous Closure. Pediatr Cardiol
2018;39:168-75.
98. Yan C, Wang C, Pan X, Li S, Song H, et al. Three-dimensional printing assisted transcatheter closure of atrial septal defect with
deficient posterior-inferior rim. Catheter Cardiovasc Interv 2018;92:1309-14.
99. Amedro P, Bayburt S, Assaidi A, Kreitmann B, Habib G, et al. Should transcatheter closure of atrial septal defects with inferior-posterior
deficient rim still be attempted? J Thorac Dis 2019;11:708-16.
100. Levi DS, Moore JW. Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 2004;61:543-7.
101. Rosenfeld HM, van der Velde ME, Sanders SP, Colan SD, Parness IA, et al. Echocardiographic predictors of candidacy for successful
transcatheter atrial septal defect closure. Cathet Cardiovasc Diagn 1995;34:29-34.
102. Ramalingam R, Patil S, Setty N, Kharge J, Puttegowda B, et al. Tough, but not impossible-Retrieval of large atrial septal occluder
devices embolized to left atrium. Interv Med Appl Sci 2017;9:42-6.
103. Nakagawa K, Akagi T, Taniguchi M, Kijima Y, Goto K, et al. Transcatheter closure of atrial septal defect in a geriatric population.
Catheter Cardiovasc Interv 2012;80:84-90.
104. Agarwal S, Sud K, Menon V. Nationwide hospitalization trends in adult congenital heart disease across 2003-2012. J Am Heart Assoc
2016;5:e002330.
105. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the US. J Am Coll Cardiol
2009;54:460-7.
106. Burchill LJ, Gao L, Kovacs AH, Opotowsky AR, Maxwell BG, et al. Hospitalization trends and health resource use for adult congenital
heart disease-related heart failure. J Am Heart Assoc 2018;7:e008775.
107. Khan A, Tan J, Li W, Dimopoulos K, Spence M, et al. The impact of transcatheter atrial septal defect closure in the older population: a
prospective study. JACC Cardiovasc Interv 2010;3:276-81.
108. Komar M, Przewlocki T, Olszowska M, Sobien B, Podolec P. The benefit of atrial septal defect closure in elderly patients. Clin Interv
Aging 2014;9:1101.
109. Thilén M, Christersson C, Dellborg M, Mattsson E, Trzebiatowska-Krzynska A, et al. Catheter closure of atrial septal defect in the
elderly (≥ 65 years). A worthwhile procedure. Int J Cardiol 2016;218:25-30.
110. Okamoto H. Perioperative anesthetic management of adult patients with congenital heart disease. Adult Congenital Heart Disease.
Springer; 2017. pp. 89-94.
111. Faccini A, Butera G. Atrial septal defect (ASD) device trans-catheter closure: limitations. J Thorac Dis 2018;10:S2923-30.
112. Ewert P, Berger F, Nagdyman N, Kretschmar O, Dittrich S, et al. Masked left ventricular restriction in elderly patients with atrial septal
defects: a contraindication for closure? Catheter Cardiovasc Interv 2001;52:177-80.
113. Miranda WR, Hagler DJ, Reeder GS, Warnes CA, Connolly HM, et al. Temporary balloon occlusion of atrial septal defects in suspected
or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings. Catheter Cardiovasc Interv 2019;93:1069-75.
114. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in
the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18:533-47.
115. Heath D, Helmholz HF Jr, Burchell HB, Dushane JW, Kirklin JW, et al. Relation between structural change in the small pulmonary
arteries and the immediate reversibility of pulmonary hypertension following closure of ventricular and atrial septal defects. Circulation
1958;18:1167-74.
116. Yong G, Khairy P, De Guise P, Dore A, Marcotte F, et al. Pulmonary arterial hypertension in patients with transcatheter closure of
secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv 2009;2:455-62.
117. Horer J, Eicken A, Muller S, Schreiber C, Cleuziou J, et al. Risk factors for prolonged intensive care treatment following atrial septal
defect closure in adults. Int J Cardiol 2008;125:57-61.
118. Zwijnenburg R, Baggen V, Witsenburg M, Roos-Hesselink J, Van Den Bosch A. Prediction of pulmonary hypertension long-term after
atrial septal defect closure. Eur Heart J 2017;38.
119. Kijima Y, Akagi T, Takaya Y, Akagi S, Nakagawa K, et al. Treat and repair strategy in patients with atrial septal defect and significant
pulmonary arterial hypertension. Circulation 2015;80:227-34.